Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer

NCT05946213 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT05946213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05946213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Phase III 'High Five Trial' Five Fraction Radiation For High-Risk Prostate Cancer
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Recruiting
Start date
December 14, 2023
Completion date
March 31, 2041
Enrollment
1,209 (estimated)
Sites
413

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, stage iii prostate cancer ajcc v8, stage iva prostate cancer ajcc v8